These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 2255069)
21. [Recombinant human erythropoietin in the treatment of anemia associated with lymphoproliferative diseases--chronic lymphadenosis and multiple myeloma]. Haber J; Spicka I; Petruzelka L; Kolesková E; Straub J; Jonásová A; Pospísilová B Vnitr Lek; 1996 Apr; 42(4):262-7. PubMed ID: 8693713 [TBL] [Abstract][Full Text] [Related]
22. Effect of recombinant human erythropoietin on the anemia of chronic renal failure. Urabe A; Takaku F; Mizoguchi H; Kubo K; Ota K; Shimizu N; Tanaka K; Mimura N; Nihei H; Koshikawa S Int J Cell Cloning; 1988 May; 6(3):179-91. PubMed ID: 3397592 [TBL] [Abstract][Full Text] [Related]
23. Human recombinant erythropoietin treatment in transfusion dependent anemic patients on maintenance hemodialysis. Zehnder C; Blumberg A Clin Nephrol; 1989 Feb; 31(2):55-9. PubMed ID: 2920469 [TBL] [Abstract][Full Text] [Related]
24. [Human recombinant erythropoietin in the treatment of the anemia of multiple myeloma]. Valladares Ayerbes MJ; Valenzuela Claros JC; Reina Zoilo JJ; Ruiz Borrego M; Moreno Nogueira JA An Med Interna; 1997 Nov; 14(11):593-4. PubMed ID: 9445590 [No Abstract] [Full Text] [Related]
25. Recombinant human erythropoietin treatment: investigational new drug protocol for the anemia of the acquired immunodeficiency syndrome. Overall results. Phair JP; Abels RI; McNeill MV; Sullivan DJ Arch Intern Med; 1993 Dec; 153(23):2669-75. PubMed ID: 8250662 [TBL] [Abstract][Full Text] [Related]
26. Improvement of anemia by recombinant erythropoietin in patients with myelodysplastic syndromes and aplastic anemia. Bessho M; Jinnai I; Matsuda A; Saito M; Hirashima K Int J Cell Cloning; 1990 Nov; 8(6):445-58. PubMed ID: 2273298 [TBL] [Abstract][Full Text] [Related]
27. [Remarkable improvement of anemia by administration of recombinant human erythropoietin in a patient with aplastic anemia]. Misago M; Mori N; Hoshuyama T; Tsukada J; Morimoto I; Oda S; Chiba S; Eto S Rinsho Ketsueki; 1991 Aug; 32(8):912-4. PubMed ID: 1942534 [TBL] [Abstract][Full Text] [Related]
28. Erythropoietin--advent of a new treatment. Winearls C Practitioner; 1987 Oct; 231(1436):1269-73. PubMed ID: 3333088 [No Abstract] [Full Text] [Related]
29. [Evaluation of treatment of anemia with erythropoietin in patients with multiple myeloma]. Adam Z; Krahulová M; Spelda S; Vorlícek J; Hejlová N; Hájek R; Tomíska M Vnitr Lek; 1995 Nov; 41(11):767-72. PubMed ID: 8553596 [TBL] [Abstract][Full Text] [Related]
30. Use of recombinant human erythropoietin for management of anemia in dogs and cats with renal failure. Cowgill LD; James KM; Levy JK; Browne JK; Miller A; Lobingier RT; Egrie JC J Am Vet Med Assoc; 1998 Feb; 212(4):521-8. PubMed ID: 9491159 [TBL] [Abstract][Full Text] [Related]
31. Trilineage recovery by combination therapy with recombinant human granulocyte colony-stimulating factor and erythropoietin in patients with aplastic anemia and refractory anemia. Bessho M; Jinnai I; Hirashima K; Saito M; Murohashi I; Ino H; Tsuji M; Fukuda M; Maruyama M; Kusumoto S Stem Cells; 1994 Nov; 12(6):604-15. PubMed ID: 7533579 [TBL] [Abstract][Full Text] [Related]
32. Increase of bone marrow cellularity during erythropoietin treatment in myeloma. Ludwig H; Chott A; Fritz E; Krainer M Stem Cells; 1995 Aug; 13 Suppl 2():77-87. PubMed ID: 8520516 [TBL] [Abstract][Full Text] [Related]
33. [Autologous blood transfusion with erythropoietin in heart surgery in an anemic patient]. Watanabe Y; Fuse K; Naruse Y; Kobayashi T; Konishi H; Shibata Y Nihon Kyobu Geka Gakkai Zasshi; 1992 Feb; 40(2):282-5. PubMed ID: 1593170 [TBL] [Abstract][Full Text] [Related]
34. Erythropoietin treatment of erythropoietin-deficient anemia without renal disease during pregnancy. Harris SA; Payne G; Putman JM Obstet Gynecol; 1996 May; 87(5 Pt 2):812-4. PubMed ID: 8677097 [TBL] [Abstract][Full Text] [Related]
35. r-HuEPO treatment of anemia associated with multiple myeloma and ESRD. Van der Niepen P; Sennesael J; Verbeelen D Clin Nephrol; 1993 Feb; 39(2):113. PubMed ID: 8448915 [No Abstract] [Full Text] [Related]
36. [Treatment of anemia in myelodysplastic syndromes with recombinant human erythropoietin]. Rodríguez JN; Prados D; Martino ML; Muñiz R Sangre (Barc); 1993 Aug; 38(4):340-1. PubMed ID: 8235952 [No Abstract] [Full Text] [Related]
37. [Erythropoietin treatment of tumor-associated anemia in patients with multiple myeloma]. Ludwig H; Fritz E; Kotzmann H; Gisslinger H Onkologie; 1990 Feb; 13(1):46-9. PubMed ID: 2186325 [TBL] [Abstract][Full Text] [Related]
38. [Effectiveness of recombinant human erythropoietin in the treatment of transfusion-dependent anemia in patients on chronic dialysis]. Graf H; Mayer G; Cada EM; Thum J; Stummvoll HK Wien Klin Wochenschr; 1987 Dec; 99(24):855-9. PubMed ID: 3439185 [TBL] [Abstract][Full Text] [Related]
39. Monitoring considerations in recombinant human erythropoietin therapy. Ogden DA Semin Nephrol; 1989 Mar; 9(1 Suppl 2):12-5. PubMed ID: 2669080 [TBL] [Abstract][Full Text] [Related]
40. [Successful treatment of anemia in hemolysis patients using recombinant human erythropoietin. Maintenance dosage and serum concentration]. Stutz B; Rhyner K; Vögtli J; Binswanger U Schweiz Med Wochenschr; 1987 Sep; 117(38):1397-402. PubMed ID: 3672079 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]